Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI-shock registry results.
Chiara FraccaroRui Campante TelesDidier TchétchéFrancesco SaiaFrancesco BedogniMatteo MontorfanoClaudia FiorinaFrancesco MeucciMauro De BenedictisOrnella LeonziMarco BarbieratoNicolas DumonteilMiroslava StolcovaDiego MaffeoMiriam CompagnoneJoão BritoAlaide ChieffoFrancesco CardaioliPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
TAVI seems to be a therapeutic option for patients with CS and SAS or degenerated aortic bioprosthesis in terms of both safety and efficacy at early and long-term follow-up.